Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LIN vs MRNA✓SelectedUSD · MRNALIN vs MRNA performance historyLatest closeAs of-1.45%11/20
Stock and ETF performance explorer

LIN vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+271.2%
MRNA return
+786.4%
Excess return
-515.2%
Maximum drawdown
-32.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.4%-2.2%+0.7%-1.4%
7D-4.4%-12.7%+8.3%-4.1%
30D+0.5%-20.7%+21.1%+0.9%
3M+4.8%+46.3%-41.4%+3.5%
6M-0.1%+305.2%-305.3%-6.5%
YTD+19.1%+561.2%-542.2%+8.5%
1Y+24.8%+772.1%-747.3%+12.1%
3Y+28.0%+147.0%-119.0%+19.3%
5Y+62.0%-26.1%+88.0%+55.3%
All+271.2%+786.4%-515.2%+224.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling